Allergen immunotherapy during the COVID‐19 pandemic—A survey of the German Society for Allergy and Clinical Immunology

BACKGROUND: When the coronavirus pandemic 2019 (COVID‐19) emerged, concerns were also raised regarding the safety of allergen immunotherapy (AIT). The German Society for Allergology and Clinical Immunology (DGAKI) conducted a survey to collect real‐world data on the daily routine of administering su...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfaar, Oliver, Hamelmann, Eckard, Klimek, Ludger, Taube, Christian, Vogelberg, Christian, Wagenmann, Martin, Werfel, Thomas, Worm, Margitta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967257/
https://www.ncbi.nlm.nih.gov/pubmed/35344300
http://dx.doi.org/10.1002/clt2.12134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967257/
https://www.ncbi.nlm.nih.gov/pubmed/35344300
http://dx.doi.org/10.1002/clt2.12134

Ejemplares similares